or
forgot password

    • cancer clinical trials in omaha, NE

    • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Creighton University Medical Center

    Trial Locations
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Breast Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Nebraska Methodist Hospital

    Trial Locations
    Nebraska Methodist Hospital
    Devetten, Marcel
    Myeloid Leukemia, Chronic, Chronic-Phase
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Children's Hospital and Medical Center of Omaha
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Methodist Cancer Center
    Omaha, Nebraska 68114
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Methodist Cancer Center at Methodist Hospital - Omaha
    Omaha, Nebraska 68114
    Fallopian Tube Cancer, Ovarian Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Omaha, Nebraska 68198-7680
    Non-Hodgkin's Lymphoma
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Creighton University Medical Center

    Trial Locations
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Immanuel Medical Center

    Trial Locations
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Head and Neck Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Prostate Cancer
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Omaha, Nebraska 68114
    Glioblastoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer